公开(公告)号：US12029820B2

公开(公告)日：2024-07-09

申请号：US17374285

申请日：2021-07-13

申请人： Acorda Therapeutics, Inc.

发明人： Joseph E. Cobb, Jr. ,  Thomas B. Gold ,  Rohini D'Souza ,  Susan L. Way

IPC分类号： A61K9/28 ,  A61K9/20 ,  A61K31/4409

CPC分类号： A61K9/2866 ,  A61K9/2009 ,  A61K9/2013 ,  A61K9/2027 ,  A61K9/2031 ,  A61K9/2095 ,  A61K9/2893 ,  A61K31/4409

摘要： The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.

公开(公告)号：US20220323362A1

公开(公告)日：2022-10-13

申请号：US17531032

申请日：2021-11-19

申请人： Acorda Therapeutics, Inc.

发明人： Joseph E. Cobb, JR. ,  Thomas B. Gold ,  Rohini D'Souza ,  Susan L. Way

IPC分类号： A61K9/20 ,  A61K9/28 ,  A61K31/4409

摘要： The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.

公开(公告)号：US20180344649A1

公开(公告)日：2018-12-06

申请号：US15764160

申请日：2016-09-28

申请人： Acorda Therapeutics, Inc.

发明人： Joseph E. Cobb, Jr. ,  Thomas B. Gold ,  Rohini D'Souza ,  Susan L. Way

IPC分类号： A61K9/28 ,  A61K31/4409 ,  A61K9/20

CPC分类号： A61K9/2866 ,  A61K9/2893 ,  A61K31/4409

摘要： The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.

公开(公告)号：US20240050376A1

公开(公告)日：2024-02-15

申请号：US18488349

申请日：2023-10-17

申请人： Acorda Therapeutics, Inc.

发明人： Joseph E. Cobb, JR. ,  Thomas B. Gold ,  Rohini D'Souza ,  Susan L. Way

IPC分类号： A61K9/20 ,  A61K9/28 ,  A61K31/4409

CPC分类号： A61K9/2027 ,  A61K9/2031 ,  A61K9/2866 ,  A61K9/2893 ,  A61K9/2009 ,  A61K9/2013 ,  A61K9/2095 ,  A61K31/4409

摘要： The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.

公开(公告)号：US20210338590A1

公开(公告)日：2021-11-04

申请号：US17374285

申请日：2021-07-13

申请人： Acorda Therapeutics, Inc.

发明人： Joseph E. Cobb, JR. ,  Thomas B. Gold ,  Rohini D'Souza ,  Susan L. Way

IPC分类号： A61K9/28 ,  A61K31/4409 ,  A61K9/20

摘要： The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.

公开(公告)号：US20210085614A1

公开(公告)日：2021-03-25

申请号：US17111845

申请日：2020-12-04

申请人： Acorda Therapeutics, Inc.

发明人： Joseph E. Cobb, Jr. ,  Thomas B. Gold ,  Rohini D'Souza ,  Susan L. Way

IPC分类号： A61K9/28 ,  A61K31/4409 ,  A61K9/20

摘要： The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.

公开(公告)号：US20200253880A1

公开(公告)日：2020-08-13

申请号：US16827130

申请日：2020-03-23

申请人： Acorda Therapeutics, Inc.

发明人： Joseph E. Cobb, JR. ,  Thomas B. Gold ,  Rohini D'Souza ,  Susan L. Way

IPC分类号： A61K9/28 ,  A61K31/4409 ,  A61K9/20

摘要： The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.